We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

80 hedge funds and large institutions have $160M invested in Repros Therapeutics Inc. in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

32% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 22

27% more call options, than puts

Call options by funds: $7.36M | Put options by funds: $5.78M

7% more funds holding

Funds holding: 75 → 80 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less capital invested

Capital invested by funds: $199M → $160M (-$38.9M)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
29
Reduced
22
Closed
13
Calls
$7.36M
Puts
$5.78M
Net Calls
+$1.58M
Net Calls Change
-$3.21M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.86M
2
RA
Royce & Associates
New York
+$2.14M
3
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$1.41M
4
AGCJ
Alden Global Capital (Jersey)
Jersey
+$1.31M
5
CC
CQS Cayman
Cayman Islands
+$1.28M

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$10M
2
PC
Paulson & Co
New York
-$9.9M
3
BBA
Baker Bros. Advisors
New York
-$6.64M
4
BIM
Bogle Investment Management
Massachusetts
-$6.46M
5
State Street
State Street
Massachusetts
-$6.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.27M +$64K +7,509 +6%
TCIM
27
TIAA CREF Investment Management
New York
$1.26M +$245K +28,726 +29%
JGC
28
J. Goldman & Co
New York
$1.26M +$861K +101,000 +404%
Barclays
29
Barclays
United Kingdom
$1.16M -$365K -42,770 -25%
ST
30
Spot Trading
Illinois
$1.03M +$498K +58,455 +131%
SFM
31
Sphera Funds Management
Israel
$997K +$853K +100,000 New
HCMT
32
Highland Capital Management (Texas)
Texas
$937K +$801K +93,941 New
GC
33
Guggenheim Capital
Illinois
$802K +$685K +80,353 New
PP
34
PDT Partners
New York
$715K -$242K -28,416 -28%
BIM
35
BlackRock Investment Management
Delaware
$699K +$16.5K +1,935 +3%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$624K -$491K -57,551 -48%
CS
37
Credit Suisse
Switzerland
$525K -$1M -117,820 -69%
PPA
38
Parametric Portfolio Associates
Washington
$520K +$445K +52,133 New
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$459K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$451K +$22K +2,582 +6%
PP
41
Paloma Partners
Connecticut
$355K +$303K +35,581 New
ID
42
Integral Derivatives
New York
$352K +$301K +35,266 New
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$334K -$28.4K -3,325 -9%
Charles Schwab
44
Charles Schwab
California
$327K – – –
TA
45
Teachers Advisors
New York
$326K -$40.5K -4,749 -13%
NCCM
46
Nine Chapters Capital Management
New Jersey
$312K -$41.8K -4,900 -14%
PAAMCP
47
Pacific Alternative Asset Management Company (PAAMCO)
California
$294K +$251K +29,444 New
AllianceBernstein
48
AllianceBernstein
Tennessee
$288K -$44.3K -5,200 -15%
Dimensional Fund Advisors
49
Dimensional Fund Advisors
Texas
$264K – – –
Citadel Advisors
50
Citadel Advisors
Florida
$261K -$751K -88,065 -77%
1
2
3 4

RPRX Hedge Fund Activity: Q4 2014 in Review

80 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q4 2014, worth a combined $160M — down 20% from $199M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RPRX positions and 13 closed out — a net gain of 6 holders — while 29 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $4.86M. The largest seller was Oracle Investment Management, exiting entirely with an estimated $10M sold.

  • 80 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q4 2014, up from 75 in Q3 2014.
  • Funds reported $160M of Repros Therapeutics Inc. stock for Q4 2014, down 20% quarter-over-quarter.
  • 19 funds opened new Repros Therapeutics Inc. positions in Q4 2014 and 13 closed out, a net change of +6 holders.
  • The largest Repros Therapeutics Inc. buyer in Q4 2014 was Fidelity Investments, an estimated $4.86M added.
  • The largest Repros Therapeutics Inc. seller in Q4 2014 was Oracle Investment Management, an estimated $10M sold.

Based on aggregated 13F filings for Q4 2014.